OAKLX
Price
$85.26
Change
+$0.33 (+0.39%)
Updated
Sep 17 closing price
Net Assets
7.48B
VVIAX
Price
$72.23
Change
+$0.31 (+0.43%)
Updated
Sep 17 closing price
Net Assets
202.84B
Interact to see
Advertisement

OAKLX vs VVIAX

Header iconOAKLX vs VVIAX Comparison
Open Charts OAKLX vs VVIAXBanner chart's image
Oakmark Select Investor
Price$85.26
Change+$0.33 (+0.39%)
VolumeN/A
Net Assets7.48B
Vanguard Value Index Adm
Price$72.23
Change+$0.31 (+0.43%)
VolumeN/A
Net Assets202.84B
OAKLX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OAKLX vs. VVIAX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OAKLX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. OAKLX (7.48B). VVIAX pays higher dividends than OAKLX: VVIAX (2.10) vs OAKLX (0.29). OAKLX was incepted earlier than VVIAX: OAKLX (29 years) vs VVIAX (25 years). OAKLX (0.99) is less costly to investors than VVIAX (0.05). OAKLX is a more actively managed with annual turnover of: 57.00 vs. VVIAX (9.00). OAKLX has a lower initial minimum investment than VVIAX: OAKLX (0) vs VVIAX (3000). OAKLX annual gain was more profitable for investors over the last year : 15.20 vs. VVIAX (6.87). OAKLX return over 5 years is better than : 121.31 vs. VVIAX (73.52).
OAKLXVVIAXOAKLX / VVIAX
Total Expense Ratio0.990.051,980%
Annual Report Gross Expense Ratio0.990.051,980%
Fund Existence29 years25 years-
Gain YTD6.3898.95671%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.48B203B4%
Annual Yield % from dividends0.292.1014%
Returns for 1 year15.206.87221%
Returns for 3 years64.3938.36168%
Returns for 5 years121.3173.52165%
Returns for 10 years128.91137.9293%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RYAM6.950.34
+5.14%
Rayonier Advanced Materials
APDN2.930.05
+1.74%
Applied DNA Sciences Inc
ARQT17.150.18
+1.06%
Arcutis Biotherapeutics
CBAT0.87N/A
N/A
CBAK Energy Technology
WLK86.96-0.74
-0.84%
Westlake Corp